Erythromycin lactobionate
Erythromycin Lactobionate is a prescription antibiotic used to treat bacterial infections. It's administered intravenously as a powder that must be mixed into a solution before use. Each vial contains 500 mg of erythromycin base. Manufactured by Gland Pharma Limited under ANDA 216761. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Erythromycin Lactobionate is a prescription antibiotic used to treat bacterial infections. It's administered intravenously as a powder that must be mixed into a solution before use. Each vial contains 500 mg of erythromycin base. Manufactured by Gland Pharma Limited under ANDA 216761. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Erythromycin lactobionate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Erythromycin lactobionate — ANDA 215290 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215290"
}
]
|
| identifier | ANDA215290 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"health-care",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Erythromycin lactobionate |
